Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamutal Engel

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
ACS Chemical Biology|May 5, 2017
Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida CellsRaphael I Benhamou, Maayan Bibi, Kfir B Steinbuch, et al.
Nature Communications|October 20, 2020
Structural basis of heterotetrameric assembly and disease mutations in the human cis-prenyltransferase complexMichal Lisnyansky Bar-El, Pavla Vaňková, Adva Yeheskel, et al.
International Journal of Biological Macromolecules|December 21, 2020
Inhibition of amyloid fibrillation of γD-crystallin model peptide by the cochineal CarmineMalak Abu-Hussien, Guru Krishnakumar Viswanathan, Lia Borisover, et al.
Biophysical Chemistry|March 3, 2024
Targeting phenylalanine assemblies as a prospective disease-modifying therapy for phenylketonuriaShira Shaham-Niv, Assaf Ezra, Dor Zaguri, et al.
International Journal of Molecular Sciences|September 10, 2021
Chemical Chaperones Modulate the Formation of Metabolite AssembliesHanaa Adsi, Shon A Levkovich, Elvira Haimov, et al.
Cellular and Molecular Life Sciences : CMLS|September 29, 2019
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal modelGuru Krishnakumar Viswanathan, Dana Shwartz, Yelena Losev, et al.
Nature Communications|January 10, 2019
Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulationDana Laor, Dorin Sade, Shira Shaham-Niv, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K<sup>+</sup> channels for atrial fibrillation treatmentShira Burg, Shir Shapiro, Asher Peretz, et al.
Scientific Reports|April 25, 2020
A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease modelsJavier Ganz, Talya Shacham, Maria Kramer, et al.
EMBO Molecular Medicine|September 6, 2021
Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolismOr Kakhlon, Hilla Vaknin, Kumudesh Mishra, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ACS Chemical Biology|May 5, 2017
Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida CellsRaphael I Benhamou, Maayan Bibi, Kfir B Steinbuch, et al.
Nature Communications|October 20, 2020
Structural basis of heterotetrameric assembly and disease mutations in the human cis-prenyltransferase complexMichal Lisnyansky Bar-El, Pavla Vaňková, Adva Yeheskel, et al.
International Journal of Biological Macromolecules|December 21, 2020
Inhibition of amyloid fibrillation of γD-crystallin model peptide by the cochineal CarmineMalak Abu-Hussien, Guru Krishnakumar Viswanathan, Lia Borisover, et al.
Biophysical Chemistry|March 3, 2024
Targeting phenylalanine assemblies as a prospective disease-modifying therapy for phenylketonuriaShira Shaham-Niv, Assaf Ezra, Dor Zaguri, et al.
International Journal of Molecular Sciences|September 10, 2021
Chemical Chaperones Modulate the Formation of Metabolite AssembliesHanaa Adsi, Shon A Levkovich, Elvira Haimov, et al.
Cellular and Molecular Life Sciences : CMLS|September 29, 2019
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal modelGuru Krishnakumar Viswanathan, Dana Shwartz, Yelena Losev, et al.
Nature Communications|January 10, 2019
Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulationDana Laor, Dorin Sade, Shira Shaham-Niv, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K<sup>+</sup> channels for atrial fibrillation treatmentShira Burg, Shir Shapiro, Asher Peretz, et al.
Scientific Reports|April 25, 2020
A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease modelsJavier Ganz, Talya Shacham, Maria Kramer, et al.
EMBO Molecular Medicine|September 6, 2021
Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolismOr Kakhlon, Hilla Vaknin, Kumudesh Mishra, et al.
Pageof 2